India · Delayed Price · Currency is INR Astec LifeSciences Statistics
Total Valuation
BOM:533138 has a market cap or net worth of INR 15.39 billion. The enterprise value is 19.78 billion.
| Market Cap | 15.39B |
| Enterprise Value | 19.78B |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.18% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 8.17% |
| Owned by Institutions (%) | 3.02% |
| Float | 5.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 71.26 |
| PS Ratio | 3.43 |
| PB Ratio | 3.94 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.15.
| Current Ratio | 0.89 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.21 |
| Interest Coverage | -1.45 |
Financial Efficiency
Return on equity (ROE) is -25.84% and return on invested capital (ROIC) is -6.18%.
| Return on Equity (ROE) | -25.84% |
| Return on Assets (ROA) | -3.39% |
| Return on Invested Capital (ROIC) | -6.18% |
| Return on Capital Employed (ROCE) | -11.17% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.51M |
| Profits Per Employee | -1.72M |
| Employee Count | 555 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.07 |
Taxes
| Income Tax | -1.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.76% |
| 50-Day Moving Average | 734.11 |
| 200-Day Moving Average | 691.90 |
| Relative Strength Index (RSI) | 42.19 |
| Average Volume (20 Days) | 1,938 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533138 had revenue of INR 4.48 billion and -809.18 million in losses. Loss per share was -37.79.
| Revenue | 4.48B |
| Gross Profit | 1.40B |
| Operating Income | -493.82M |
| Pretax Income | -810.00M |
| Net Income | -809.18M |
| EBITDA | -52.80M |
| EBIT | -493.82M |
| Loss Per Share | -37.79 |
Balance Sheet
The company has 100.49 million in cash and 4.49 billion in debt, with a net cash position of -4.39 billion.
| Cash & Cash Equivalents | 100.49M |
| Total Debt | 4.49B |
| Net Cash | -4.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.91B |
| Book Value Per Share | 175.30 |
| Working Capital | -567.95M |
Cash Flow
In the last 12 months, operating cash flow was -807.08 million and capital expenditures -55.36 million, giving a free cash flow of -862.44 million.
| Operating Cash Flow | -807.08M |
| Capital Expenditures | -55.36M |
| Depreciation & Amortization | 449.22M |
| Net Borrowing | -1.09B |
| Free Cash Flow | -862.44M |
| FCF Per Share | n/a |
Margins
Gross margin is 31.21%, with operating and profit margins of -11.02% and -18.06%.
| Gross Margin | 31.21% |
| Operating Margin | -11.02% |
| Pretax Margin | -18.07% |
| Profit Margin | -18.06% |
| EBITDA Margin | -1.18% |
| EBIT Margin | -11.02% |
| FCF Margin | n/a |
Dividends & Yields
BOM:533138 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.18% |
| Shareholder Yield | -9.18% |
| Earnings Yield | -5.26% |
| FCF Yield | -5.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for BOM:533138 is 622.50, which is -9.88% lower than the current price. The consensus rating is "Hold".
| Price Target | 622.50 |
| Price Target Difference | -9.88% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 27.34% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOM:533138 has an Altman Z-Score of 2.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 4 |